Phosphonium betaines derived from hexafluoro-1,4-naphthoquinone: Synthesis and cytotoxic and antioxidant activities

Pines, 1999, Four-dimensional control of the cell cycle, Nat. Cell Biol., 1, E73, 10.1038/11041 Mueller, 1995, Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15, Science, 6, 86, 10.1126/science.270.5233.86 Kristjansdottir, 2004, Cdc25 phosphatases and cancer, J. Chem. Biol., 11, 1043, 10.1016/j.chembiol.2004.07.007 Boutros, 2006, The when and wheres of CDC25 phosphatases, Curr. Opin. Cell Biol., 18, 185, 10.1016/j.ceb.2006.02.003 Boutros, 2007, CDC25 phosphatases in cancer cells: key players? Good targets?, Nat. Rev. Cancer, 7, 495, 10.1038/nrc2169 Eckstein, 2000, Cdc25 as a potential target of anticancer agents, Invest. New Drugs, 18, 149, 10.1023/A:1006377913494 Pestell, 2000, Small molecule inhibitors of dual specificity protein phosphatases, Oncogene, 19, 6607, 10.1038/sj.onc.1204084 Lazo, 2002, Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors, Mol. Pharmacol., 61, 720, 10.1124/mol.61.4.720 Wipf, 2004, Synthesis and biological evaluation of caulibugulones A-E, Org. Biomol. Chem., 2, 2173, 10.1039/B408184F Lazo, 2001, Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25, J. Med. Chem., 44, 4042, 10.1021/jm0102046 Nishikawa, 1995, Growth inhibition of hepatoma cells induced by vitamin K and its analogs, J. Biol. Chem., 270, 28304, 10.1074/jbc.270.47.28304 Wardman, 2001, Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia, Curr. Med. Chem., 8, 739, 10.2174/0929867013372959 Ham, 2004, Fluorinated quinoid inhibitor: possible “pure” arylator predicted by the simple theoretical calculation, Bioorg. Med. Chem. Lett., 14, 4103, 10.1016/j.bmcl.2004.05.009 Kar, 2006, Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK, Biochem. Pharmacol., 72, 1217, 10.1016/j.bcp.2006.07.024 Park, 2007, Fluorinated NSC as a Cdc25 inhibitor, Bioorg. Med. Chem. Lett., 17, 2351, 10.1016/j.bmcl.2006.12.046 Zakharova, 2010, Cytotoxicity of new n-butylamino and sulfur-containing derivatives of polyfluorinated 1,4-naphthoquinone, Eur. J. Med. Chem., 45, 270, 10.1016/j.ejmech.2009.10.006 Zakharova, 2010, Cytotoxicity of new alkylamino- and phenylamino-containing polyfluorinated derivatives of 1,4-naphthoquinone, Eur. J. Med. Chem., 45, 2321, 10.1016/j.ejmech.2010.02.009 Goryunov, 2009, Synthesis of 2-aminopentafluoro-1,4-naphthoquinone derivatives, Russ. J. Org. Chem., 45, 835, 10.1134/S1070428009060050 Goryunov, 2011, Synthesis of diphenyl(X)phosphonium betaines (X=CH3, C6H5, 2,5-F2C6H3) from hexafluoro-1,4-naphthoquinone, ARKIVOC, 185, 10.3998/ark.5550190.0012.814 Reddy, 1970, 31P and 19F nuclear magnetic resonance studies of phosphorus-fluorine compounds, Z. Naturforsch., 25b, 1199, 10.1515/znb-1970-1101 Grushin, 2000, Thermal stability, decomposition paths, and Ph/Ph exchange reactions of [(Ph3P)2Pd(Ph)X] (X=I, Br, Cl, F, and HF2), Organometallics, 19, 1888, 10.1021/om0001265 Zhivetyeva, 2015, Triphenylphosphanodefluorination of fluoranil and its derivatives, J. Fluorine Chem., 180, 21, 10.1016/j.jfluchem.2015.08.018 Ramirez, 1956, The structure of quinone-donor adducts. I. The action of triphenylphosphine on p-benzoquinone, 2,5-dichloro-p-benzoquinone and chloranil, J. Am. Chem. Soc., 78, 5614, 10.1021/ja01602a041 Allen, 1987, Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds, J. Chem. Soc. Perkin Trans. II, S1, 10.1039/p298700000s1 G.A. Nevinsky, O.D. Zakharova, L.I. Goryunov, V.D. Shteingarts, S.I. Zhivetyeva, Phosphorus-containing fluorinated 1,4-naphthoquinone derivatives, possessing cytotoxic naphthoquinone derivatives, possessing cytotoxic activity with respect to human cancer cells in culture, RU Patent 2535676, 2014. Reynolds, 1999, Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle, J. Mol. Biol., 293, 559, 10.1006/jmbi.1999.3168 Lavecchia, 2012, Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening, J. Med. Chem., 55, 4142, 10.1021/jm201624h Maron, 1983, Revised methods for the Salmonella mutagenicity test, Mutat. Res., 113, 173, 10.1016/0165-1161(83)90010-9 Kemeleva, 2008, New promising antioxidants based on 2,6-dimethylphenol, Bioorg. Khim. (Moscow), 34, 558 Sheldrick, 1997 Spek, 2003, Single-crystal structure validation with the program PLATON, J. Appl. Crystallogr., 36, 7, 10.1107/S0021889802022112 Mosmann, 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65, 55, 10.1016/0022-1759(83)90303-4 Trott, 2010, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading, J. Comput. Chem., 31, 455 Halgren, 1996, Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94, J. Comput. Chem., 17, 490, 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P